Trials / Active Not Recruiting
Active Not RecruitingNCT06625242
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
A Multicenter, Open-label, Single-arm, Phase 4 Study to Evaluate the Efficacy and Safety of Filgotinib in Korean Patients With Rheumatoid Arthritis
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- Eisai Korea Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to assess the percentage of participants achieving an American College of Rheumatology (ACR) 20 percent (%) Improvement (ACR20) response at Week 12 of the administration of the investigational product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Filgotinib Maleate | Administered as oral tablets. |
Timeline
- Start date
- 2024-10-22
- Primary completion
- 2026-02-26
- Completion
- 2026-03-19
- First posted
- 2024-10-03
- Last updated
- 2025-09-30
Locations
15 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06625242. Inclusion in this directory is not an endorsement.